Table 2.
Outcome Variable |
Cohort 1 (n=89) | Cohort 2 (n=93) | Cohort 3 (n=96) | Combined Cohort (n=322) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary | Beta | OR (CI) |
p | Beta | OR (CI) |
p | Beta | OR (CI) |
p | Beta | OR (CI) |
p |
Imaging Outcome* (Fazekas) | 0.095 | 1.10 (0.93-1.30) | 0.27 | 0.249 | 1.28 (1.06-1.55) | 0.011 | 0.217 | 1.24 (1.05-1.47) | 0.011 | 0.147 | 1.16 (1.07-1.25) | 0.0003 |
Cognitive Outcome* (CDR) | 0.162 | 1.18 (0.99-1.40) | 0.068 | 0.231 | 1.26 (1.09 - 1.45) | 0.001 | 0.463 | 1.59 (1.31-1.93) | <0.0001 | 0.202 | 1.22 (1.14-1.32) | <0.0001 |
Secondary | ||||||||||||
Imaging Outcome** (vWMH) | 0.048 | 1.78e-4 | 0.057 | 2.50e-3 | 0.172 | 5.93e-5 | 0.104 | 5.42e-15 | ||||
Cognitive Outcome** (UDS3-EF) | −0.022 | 0.83 | −0.052 | 0.147 | −0.049 | 0.108 | −0.030 | 0.070 |
Age- and sex-adjusted ordinal logistic regression model using unadjusted plasma PlGF values (pg/mL).
Age- and sex-adjusted linear regression model using unadjusted plasma PlGF values (pg/mL).
CDR – Cognitive Dementia Rating Scale; vWMH – volumetric white matter hyperintensity imaging; UDS3-EF – Uniform Data Set 3.0 – Executive Function score